Atlas Trials

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

Clinical trial NCT01619046 · UNKNOWN

Trial details

NCT number
NCT01619046
Sponsor
Green Cross Corporation
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hemophilia A
Start date
2013-03-01
Primary completion
2015-07-01
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.